Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Stran & Company, Inc.STRN · Entity 9074 | Director | November 12, 2021 | November 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Stran & Company, Inc.
Report date November 12, 2021 · Filed November 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,892 |
Reported balance
After 2021-11-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-11-12 · Grant · Acquired 2,892 · Balance 2,892 F1: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.15 · Expires 2031-11-11 | Direct | 5,000 |
Reported balance
After 2021-11-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-11-12 · Grant · Acquired 5,000 · Balance 5,000 F2: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering.
F2: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 12, 2021 Filed Nov 16, 2021 15:43 UTC | Stran & Company, Inc. STRN · Entity 9074 | GrantEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $4.15 | $0.00 |
DisclosureSEC source: 0001213900-21-059826 · ownership.xml · derivative · entry 2 Tani Alejandro · CIK 0001888592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2031-11-11 F2 · derivative.exercise_date: Vest in twelve (12) equal monthly installments over the first year following the date of grant, subject to the undersigned continuing in service on the Board of Directors of the issuer through each such vesting date. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 15:43 UTC | Stran & Company, Inc. STRN · Entity 9074 | GrantCommon Stock | 2,892 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-059826 · ownership.xml · nonDerivative · entry 1 Tani Alejandro · CIK 0001888592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,892 F1 · security: Vest in four (4) equal quarterly installments commencing in the first quarter following the effectiveness date of the registration statement for the issuer's initial public offering. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.